Mimicry of a Cellular Low Energy Status Blocks Tumor Cell Anabolism and Suppresses the Malignant Phenotype
- 15 March 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 65 (6) , 2441-2448
- https://doi.org/10.1158/0008-5472.can-04-3025
Abstract
Aggressive cancer cells typically show a high rate of energy-consuming anabolic processes driving the synthesis of lipids, proteins, and DNA. Here, we took advantage of the ability of the cell-permeable nucleoside 5-aminoimidazole-4-carboxamide (AICA) riboside to increase the intracellular levels of AICA ribotide, an AMP analogue, mimicking a low energy status of the cell. Treatment of cancer cells with AICA riboside impeded lipogenesis, decreased protein translation, and blocked DNA synthesis. Cells treated with AICA riboside stopped proliferating and lost their invasive properties and their ability to form colonies. When administered in vivo, AICA riboside attenuated the growth of MDA-MB-231 tumors in nude mice. These findings point toward a central tie between energy, anabolism, and cancer and suggest that the cellular energy sensing machinery in cancer cells is an exploitable target for cancer prevention and/or therapy.Keywords
This publication has 41 references indexed in Scilit:
- Aberrant mRNA translation in cancer pathogenesis: an old concept revisited comes finally of ageOncogene, 2004
- Stimulation of the AMP-activated Protein Kinase Leads to Activation of Eukaryotic Elongation Factor 2 Kinase and to Its Phosphorylation at a Novel Site, Serine 398Journal of Biological Chemistry, 2004
- Energy restriction and the risk of spontaneous mammary tumors in mice: A meta‐analysisInternational Journal of Cancer, 2003
- AMP-activated protein kinase and hepatic genes involved in glucose metabolismBiochemical Society Transactions, 2003
- AMP-activated Protein Kinase Suppresses Protein Synthesis in Rat Skeletal Muscle through Down-regulated Mammalian Target of Rapamycin (mTOR) SignalingJournal of Biological Chemistry, 2002
- HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosisLeukemia, 2002
- A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesisPublished by Wiley ,2001
- 5-Aminoimidazole-4-Carboxamide Ribonucleoside. A Specific Method for Activating AMP-Activated Protein Kinase in Intact Cells?European Journal of Biochemistry, 1995
- AICA‐Riboside: Safety, Tolerance, and Pharmacokinetics of a Novel Adenosine‐Regulating AgentThe Journal of Clinical Pharmacology, 1991
- Identification by amino acid sequencing of three major regulatory phosphorylation sites on rat acetyl‐CoA carboxylaseEuropean Journal of Biochemistry, 1988